CompletedPhase 2NCT00610038

Efficacy and Safety Study of Sulfonylureas in Neonatal Diabetes Mellitus

Studying Neonatal diabetes mellitus

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Assistance Publique - Hôpitaux de Paris
Principal Investigator: Michel Polak, MD, PhD
Necker Hospital AP-HP
Intervention: glibenclamide(drug)
Enrollment: 19 target
Eligibility: All sexes
Timeline: 2006 – 2011

Study locations (1)

Necker Hospital - Endocrinology Gynecology Pediatric unit, Paris, France

Collaborators

URC-CIC Paris Descartes Necker Cochin

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00610038 on ClinicalTrials.gov

Other trials for Neonatal diabetes mellitus

Additional recruiting or active studies for the same condition.

See all trials for Neonatal diabetes mellitus →

← Back to all trials